1800-272-662
Shopping Cart 0
countryflagAU
Login

Osteopore Ltd

Healthcare AU OSX

0.007AUD
-0.001(12.50%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.0070.008
LowHigh

52 Week Range

0.0060.04
LowHigh

Fundamentals

  • Previous Close 0.008
  • Market Cap4.50M
  • Volume1351213
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.94126M
  • Revenue TTM3.06M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 2.37M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.72066M -3.33327M -4.82846M -4.19522M -3.62090M
Minority interest - - - - -
Net income -3.72233M -3.35244M -4.87198M -4.21560M -3.92865M
Selling general administrative - 2.21M 2.03M 4.52M 4.20M
Selling and marketing expenses - 1.48M 1.91M 1.01M 0.50M
Gross profit 1.62M 2.37M 1.64M 1.36M 1.10M
Reconciled depreciation - 0.53M 0.46M 0.22M 0.23M
Ebit -2.67028M -2.81924M -4.81342M -4.17485M -3.60460M
Ebitda -1.92161M -2.34024M -4.34902M -3.95663M -3.37913M
Depreciation and amortization 0.75M 0.48M 0.46M 0.22M 0.23M
Non operating income net other - - - - -
Operating income -2.67028M -2.81924M -4.92643M -4.17485M -3.60460M
Other operating expenses 5.73M 5.63M 7.14M 6.17M 5.23M
Interest expense 0.28M 0.43M 0.02M 0.02M 0.02M
Tax provision - 0.02M 0.04M 0.00000M 0.00000M
Interest income - 0.43M 0.00751M 0.02M 0.02M
Net interest income - -0.42602M -0.00754M -0.02038M -0.01630M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00167M 0.02M 0.04M 0.02M 0.31M
Total revenue 3.06M 2.81M 2.22M 1.78M 1.40M
Total operating expenses 4.29M 5.19M 6.10M 5.75M 4.93M
Cost of revenue 1.44M 0.45M 0.58M 0.42M 0.30M
Total other income expense net -1.05038M -0.51403M 0.10M -0.02038M -0.01630M
Discontinued operations - - - - -
Net income from continuing ops - -3.35244M -4.87198M -4.19522M -3.62090M
Net income applicable to common shares - -3.35244M -4.87198M -4.19522M -3.62090M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.77M 3.32M - 3.62M 6.01M
Intangible assets - 0.46M - - -
Earning assets - - - - -
Other current assets 0.55M 0.65M -1.11500M 0.71M 0.29M
Total liab 4.50M 2.88M - 1.51M 0.63M
Total stockholder equity -1.72630M 0.43M - 2.11M 5.37M
Deferred long term liab - - - - -
Other current liab 1.32M 0.06M - 0.07M 0.03M
Common stock 34.31M 32.60M - 27.01M 26.07M
Capital stock - - - 27.01M 26.07M
Retained earnings -21.71786M -17.95831M - -10.90219M -7.94913M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.63M 0.64M 1.11M 2.16M 4.93M
Cash and equivalents - - - 0.00540M -
Total current liabilities 3.05M 2.77M - 1.48M 0.56M
Current deferred revenue - - - - -
Net debt -0.42817M 0.69M -1.11500M -2.09076M -4.82420M
Short term debt 0.11M 1.22M - 0.05M 0.08M
Short long term debt - - - - -
Short long term debt total 0.20M 1.33M - 0.07M 0.11M
Other stockholder equity - - - -0.20141M -12.74412M
Property plant equipment - - - 0.47M 0.59M
Total current assets 2.59M 2.53M - 3.15M 5.42M
Long term investments - - - - -
Net tangible assets - - - 2.05M 5.37M
Short term investments - - - - 0.20M
Net receivables 1.05M 0.86M - 0.87M 0.40M
Long term debt - - - - -
Inventory 0.36M 0.38M - 0.28M 0.20M
Accounts payable 1.62M 1.49M - 1.37M 0.45M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -14.31552M -14.20741M - -14.00300M -12.74412M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 0.18M
Deferred long term asset charges - - - - -
Non current assets total 0.18M 0.78M - 0.47M 0.59M
Capital lease obligations - - - 0.07M 0.11M
Long term debt total - - - 0.03M 0.07M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.01459M -0.00737M -0.06398M -0.19462M
Change to liabilities - - - 0.87M -0.27485M
Total cashflows from investing activities -0.01079M -0.01459M -0.00737M -0.06398M -0.19462M
Net borrowings - - 2.22M -0.04868M -0.48588M
Total cash from financing activities 2.67M 2.63M 3.58M 0.84M -0.48588M
Change to operating activities - - - -0.37718M -0.11152M
Net income -3.72233M -3.35244M -4.87198M -4.21560M -3.62090M
Change in cash -0.00578M -0.47630M -0.21942M -3.19595M -4.49684M
Begin period cash flow 0.63M 1.11M 1.33M 4.53M 9.03M
End period cash flow 0.63M 0.64M 1.11M 1.33M 4.53M
Total cash from operating activities -2.55700M -3.08797M -3.73714M -3.99738M -3.80563M
Issuance of capital stock - 3.12M 2.69M 0.94M -
Depreciation 0.75M 0.53M 0.46M 0.22M 0.23M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.02M -0.10054M 0.00018M -0.07754M -0.05024M
Change to account receivables -0.43375M -0.31815M -0.26112M -0.42998M -0.05706M
Sale purchase of stock - -0.10957M -0.16975M -0.05407M 0.00000M
Other cashflows from financing activities -0.05784M -0.32589M -0.05224M -0.04868M -0.04294M
Change to netincome - - - 0.00072M 0.08M
Capital expenditures 0.01M 0.01M 0.00737M 0.06M 0.19M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.05657M -0.72874M 0.09M -0.02037M -0.52761M
Stock based compensation - 0.18M 0.54M - -
Other non cash items 0.47M 0.29M 0.04M 4.00M 3.40M
Free cash flow -2.56779M -3.10256M -3.74451M -4.06135M -4.00025M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OSX
Osteopore Ltd		 -0.001 12.50% 0.007 - - 1.47 15.36 2.12 -2.1957
RMD
Resmed Inc		 -0.17 0.51% 32.97 23.22 20.00 8.90 5.44 6.38 16.47
FPH
Fisher & Paykel Healthcare Corporation Ltd		 0.08 0.25% 31.95 51.53 42.55 8.69 11.33 16.61 32.26
ANN
Ansell Ltd		 -0.05 0.17% 29.75 22.58 18.08 2.14 1.54 1.80 11.96
NAN
Nanosonics Ltd		 -0.05 1.42% 3.46 49.43 50.25 5.06 4.85 4.39 28.78

Reports Covered

Stock Research & News

View All

Profile

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical implants; sells medical devices; provides technology services; and engages in research and development activities. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Osteopore Ltd

2 Tukang Innovation Grove #09-06/07, Singapore, Singapore, 6000

Key Executives

Name Title Year Born
Mr. Kei Wei Leong Exec. Chairman 1976
Mr. Khoon Seng Goh Chief Exec. Officer NA
Dr. Jing Lim COO & CTO NA
Ms. Deborah Ho AGIA, B.Com. Company Sec. 1988
Mr. Kei Wei Leong Executive Chairman 1976
Dr. Jing Lim CEO & CTO NA
Mr. Khoon Seng Goh Global Marketing Director NA
Ms. Shu Ning Voon Financial Controller NA
Ms. Kellie Davis Joint Company Secretary NA
Mr. Kei Wei Leong Executive Chairman 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.